# LifeVantage Corporation (LFVN)

**Exchange:** NASDAQ  
**Sector:** Consumer Defensive  
**Market cap:** $132M  
**Price:** $10.20 (+7.59%)

> LifeVantage Corporation is a health and wellness company headquartered in Lehi, Utah, focused on nutrigenomics and clinically researched nutritional products. The company identifies, develops, and markets nutraceutical dietary supplements designed to support cellular health, oxidative stress management, and overall well-being. Its portfolio includes branded products such as Protandim nutrigenomic activators, nootropic formulations, pre- and probiotics, energy drink mixes, weight management solutions, and skin and hair care lines. LifeVantage distributes its products primarily through a direct selling model, engaging independent distributors and customers across markets including the United States, Asia-Pacific, Europe, and Latin America. The company positions itself at the intersection of nutrition and gene expression, targeting consumers interested in proactive wellness, healthy aging, and performance support. By combining scientific research, proprietary formulations, and a network-based distribution approach, LifeVantage plays a specialized role in the global consumer health and personal care market.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $229M | $184M | $12M | $10M | — |
| 2024 | $200M | $159M | $4M | $3M | — |
| 2023 | $213M | $170M | $4M | $3M | — |
| 2022 | $206M | $168M | $8M | $3M | — |
| 2021 | $220M | $182M | $18M | $13M | — |
| 2020 | $233M | $195M | $15M | $12M | — |
| 2019 | $226M | $188M | $10M | $7M | — |
| 2018 | $203M | $168M | $10M | $6M | — |
| 2017 | $199M | $166M | $4M | $2M | — |
| 2016 | $207M | $173M | $13M | $6M | — |
| 2015 | $190M | $162M | $14M | $7M | — |
| 2014 | $214M | $181M | $19M | $11M | — |
| 2013 | $208M | $172M | $12M | $8M | — |
| 2012 | $126M | $108M | $21M | $12M | — |
| 2011 | $39M | $33M | $4M | -$51M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $72M | $37M | $35M | $20M | — |
| 2024 | $60M | $34M | $26M | $17M | — |
| 2023 | $66M | $31M | $35M | $22M | — |
| 2022 | $71M | $39M | $32M | $20M | — |
| 2021 | $79M | $42M | $37M | $23M | — |
| 2020 | $59M | $26M | $33M | $22M | — |
| 2019 | $55M | $28M | $27M | $19M | — |
| 2018 | $51M | $29M | $22M | $17M | $3M |
| 2017 | $45M | $31M | $15M | $11M | $5M |
| 2016 | $51M | $40M | $11M | $8M | $7M |
| 2015 | $40M | $36M | $2M | $14M | $9M |
| 2014 | $54M | $50M | $2M | $20M | $25M |
| 2013 | $55M | $22M | $34M | $26M | — |
| 2012 | $45M | $16M | $28M | $25M | — |
| 2011 | $12M | $33M | -$21M | $6M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $12M | $1M | $11M |
| 2024 | $12M | $2M | $10M |
| 2023 | $7M | $3M | $4M |
| 2022 | $8M | $2M | $6M |
| 2021 | $16M | $4M | $13M |
| 2020 | $18M | $3M | $16M |
| 2019 | $18M | $3M | $15M |
| 2018 | $13M | $5M | $9M |
| 2017 | $7M | $1M | $6M |
| 2016 | $6M | $562,000 | $5M |
| 2015 | $13M | $1M | $12M |
| 2014 | $12M | $2M | $10M |
| 2013 | $11M | $5M | $6M |
| 2012 | $19M | $2M | $17M |
| 2011 | $5M | $122,000 | $5M |

Source: [CompaniesByCap](https://companiesbycap.com/company/LFVN)